Status: Not yet recruiting
Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection
This purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of a bacteriophage therapy in a patient with a methicillin-susceptible Enterococcus faecium (E. faecium) prosthetic joint infection (PJI) of the hip. We have exhausted all surgical and medical management of PJI for our patient. The phage will be administered to the study patient during a 14 days period via intravenous and intra-articular. The patient will be monitored in clinic for up to 1 year.
Participants needed: 1
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: Orthopaedic Innovation CentreUpdated: Apr 24, 2025Locations: 1
Eligibility criteria
Willingness to provide signed and dated informed consent form to participate in... [+2]
below 18 years of age